GENEVA, Sept. 24 -- XELCIS BIO, INC. filed a patent application (US2026/020072) for “MULTISTAGE STIMULI-RESPONSIVE NANOPARTICLE PLATFORM FOR INTRACELLULAR DELIVERY OF BIOLOGICS AND DRUG CONJUGATES THEREOF”. With publication no. WO/2026/198863, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 9/51
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....